AVENUE SOLUTIONS for MERCK & CO. INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Antibiotics/stewardship; Value of prescription drugs; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S. 2076/H.R. 3932, PASTEUR Act of 2021; H.R. 5376, Build Back Better Act; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; ACIP recommendations related to pneumococcal vaccines; Cancer Moonshot; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 2706/H.R. 5030, DIVERSE Trials Act; Issues related to the FY 2023 Presidents Budget; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Medicare/Medicaid MMM
Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S.2076/H.R.3932, PASTEUR Act of 2021; Value of prescription drugs; Issues related to Medicare Parts B and D; Implementation of American Rescue Plan Act of 2021 (PL 117-2)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.